The abstract is read at the publisher; the summary is JClub's.
MASLD is linked to micro- and macrovascular complications in diabetes, but current evidence suggests it acts as a risk enhancer rather than an independent risk factor.
- Why it matters: Overlapping cardiometabolic risk factors between MASLD and type 2 diabetes make causality hard to confirm, and existing studies have methodological limits.
- What they did: The review synthesizes cross-sectional and longitudinal observational evidence, highlighting issues such as participant selection, diagnostic sensitivity for liver and diabetes complications, alcohol and cardiometabolic risk factor control, and lack of repeat measurements.
- The result: The authors conclude MASLD, particularly at-risk steatohepatitis with significant fibrosis ≥F2, is associated with vascular complications and should inform more proactive diabetes risk stratification until stronger causal evidence emerges.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.